Comparative analysis of viral titers and histologic features of Pakistani patients infected with hepatitis C virus type 3

International Journal of Infectious Diseases

Volumn 6, Issue 4, 2002, Pages 272-276

  Moatter, Tariq ^a   Hussainy, Akbar Shah ^a   Hamid, Saeed ^b   Ahmad, Zubair ^a   Siddiqui, Shahid ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PAKISTAN; SCHOOL CHILD; SEROTYPE; VIREMIA; VIRUS LOAD;

EID: 0036924171     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(02)90160-8     Document Type: Article

References (24)

1. Consensus Statement. EASL International Consensus Conference on Hepatitis C. J Hepatol 1999; 31:3-8.
2. Zuberi SJ. Seroepidemiology of HBV and HCV in Pakistan. Int Hep Commun 1996; 5:19-26.
3. Kakepoto GN, Bhally HS, Khaliq G, et al. Epidemiology of blood borne viruses: A study of healthy blood donors in Southern Pakistan. SE Asian J Trop Med Public Health 1996; 27:703-706.
4. Pasha O, Luby SP, Khan AJ, Shah SA, McCormick JB, Fisher-Hoch S. Household members of hepatitis C virus-infected people in Hafizabad Pakistan: Infection injections from health care providers. Epidemiol Infect 1999; 123: 515-518.
5. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74:2391-2399.
6. Hamid S, Jafri W, Khan H, Sultana T, Siddiqui A. Response to interferon treatment in 'serologically defined genotype 3' HCV infection in patients from Pakistan. Gastroenterology 1993; 1104:A1203.
7. Toyoda H, Nakano S, Kumada T, et al. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients. J Med Virol 1996; 48:354-359.
8. McHutchison JG, Gordon ST, Schiff ER, et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339:1485-1492.
9. Simmond P, Rose KA, Graham S, et al. Mapping of serotype-specific immunodominant epitopes in the NS4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infection with HCV type 1, 2, and 3. J Clin Microbiol 1993; 31:1493-1508.
10. Scheuer PJ. Classification of chronic viral hepatitis. A need for reassessment. J Hepatol 1991; 13:372-374.
11. Tong CYW, Khan R, Beeching NJ, et al. The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma. Epidemiol Infect 1996; 117:327-332.
12. Moatter T, Adil S, Haroon S, Azeemuddin S, Hassan F, Khurshid M. Prevalence of hepatitis G virus in Pakistani children with transfusion dependent beta thalassemia major. Ind J Pathol Microbiol 1999; 42:475-482.
13. Simmonds P, McOmish F, Yap L, et al. Sequence variability in the 5′ non-coding region of hepatitis C virus identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74:661-668.
14. Pawlotsky JM, Tsakiris L, Roudot F, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171:1607-1610.
15. Martinot-Perignous M, Boyer N, Pouteau M, et al. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J Hepatol 1998; 24:214-223.
16. Detmer J, Lagier R, Flynn J, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol 1996; 34:901-907.
17. Hino K, Sainokami S, Shimoda K, et al. Genotyping and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42:299-305.
18. Benvegnu L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Albert A. Lack of correlation between HCV genotypes and clinical course of HCV related cirrhosis. Hepatology 1997; 25:211-215.
19. Simmonds P. Clinical relevance of HCV genotypes. Gut 1997; 40:291-293.
20. Lefkowitch JH, Schiffer GL, Perillo RP, et al. Pathological diagnosis of chronic hepatitis C. A multicenter comparative study with chronic hepatitis B. Gastroenterology 1993; 104: 595-603.
21. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis. Hepatology 1992; 15:572-577.
22. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15: 567-571.
23. Gerber MA, Krawczunski K, Alter MJ, Sampliner RE, Margolis MS. Histopathology of community acquired chronic hepatitis C. Mod Pathol 1992; 5:483-488.
24. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998; 29:198-206.